Annual Working Capital
$6.72 M
-$2.61 M-28.01%
June 30, 2024
Summary
- As of February 7, 2025, INM annual working capital is $6.72 million, with the most recent change of -$2.61 million (-28.01%) on June 30, 2024.
- During the last 3 years, INM annual working capital has risen by +$554.90 thousand (+9.00%).
- INM annual working capital is now -65.75% below its all-time high of $19.61 million, reached on June 30, 2018.
Performance
INM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$5.84 M
-$873.80 K-13.01%
September 30, 2024
Summary
- As of February 7, 2025, INM quarterly working capital is $5.84 million, with the most recent change of -$873.80 thousand (-13.01%) on September 30, 2024.
- Over the past year, INM quarterly working capital has dropped by -$2.69 million (-31.53%).
- INM quarterly working capital is now -70.20% below its all-time high of $19.61 million, reached on June 30, 2018.
Performance
INM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
INM Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.0% | -31.5% |
3 y3 years | +9.0% | -6.9% |
5 y5 years | -48.1% | -27.8% |
INM Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -28.0% | +9.0% | -49.7% | +25.9% |
5 y | 5-year | -48.1% | +44.9% | -58.4% | +80.2% |
alltime | all time | -65.8% | +631.1% | -70.2% | +424.1% |
InMed Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.84 M(-13.0%) |
Jun 2024 | $6.72 M(-28.0%) | $6.72 M(-21.3%) |
Mar 2024 | - | $8.54 M(-15.7%) |
Dec 2023 | - | $10.13 M(+45.6%) |
Sep 2023 | - | $6.96 M(-25.5%) |
Jun 2023 | $9.33 M(+48.6%) | $9.33 M(-2.5%) |
Mar 2023 | - | $9.57 M(-17.6%) |
Dec 2022 | - | $11.62 M(+40.6%) |
Sep 2022 | - | $8.26 M(+31.6%) |
Jun 2022 | $6.28 M(+1.9%) | $6.28 M(+35.3%) |
Mar 2022 | - | $4.64 M(-41.2%) |
Dec 2021 | - | $7.89 M(-43.9%) |
Sep 2021 | - | $14.05 M(+128.0%) |
Jun 2021 | $6.16 M(+32.9%) | $6.16 M(-32.9%) |
Mar 2021 | - | $9.18 M(+13.4%) |
Dec 2020 | - | $8.10 M(+149.7%) |
Sep 2020 | - | $3.24 M(-30.1%) |
Jun 2020 | $4.64 M(-64.2%) | $4.64 M(-20.8%) |
Mar 2020 | - | $5.85 M(-28.6%) |
Dec 2019 | - | $8.20 M(-20.1%) |
Sep 2019 | - | $10.27 M(-20.6%) |
Jun 2019 | $12.94 M(-34.0%) | $12.94 M(-15.4%) |
Mar 2019 | - | $15.30 M(-8.6%) |
Dec 2018 | - | $16.75 M(-11.4%) |
Sep 2018 | - | $18.90 M(-3.6%) |
Jun 2018 | $19.61 M(+288.0%) | $19.61 M(+89.9%) |
Mar 2018 | - | $10.33 M(-0.2%) |
Dec 2017 | - | $10.34 M(+113.7%) |
Sep 2017 | - | $4.84 M(-4.3%) |
Jun 2017 | $5.06 M(-1725.0%) | $5.06 M(+148.5%) |
Mar 2017 | - | $2.03 M(+343.1%) |
Dec 2016 | - | $459.10 K(-622.9%) |
Sep 2016 | - | -$87.80 K(-71.8%) |
Jun 2016 | -$311.10 K(-323.0%) | -$311.10 K(-44.8%) |
Mar 2016 | - | -$563.20 K(+109.8%) |
Dec 2015 | - | -$268.40 K(+136.3%) |
Sep 2015 | - | -$113.60 K(-181.4%) |
Jun 2015 | $139.50 K(+20.7%) | $139.50 K(-160.4%) |
Mar 2015 | - | -$230.80 K(-34.6%) |
Dec 2014 | - | -$353.00 K(+561.0%) |
Sep 2014 | - | -$53.40 K(-146.2%) |
Jun 2014 | $115.60 K(-362.1%) | $115.60 K(-164.8%) |
Mar 2014 | - | -$178.50 K(+99.4%) |
Dec 2013 | - | -$89.50 K(+59.8%) |
Sep 2013 | - | -$56.00 K(+27.0%) |
Jun 2013 | -$44.10 K | -$44.10 K(+107.0%) |
Mar 2013 | - | -$21.30 K(+52.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2012 | - | -$14.00 K(-30.3%) |
Sep 2012 | - | -$20.10 K(-844.4%) |
Jun 2012 | $2700.00(-98.7%) | $2700.00(-97.4%) |
Mar 2012 | - | $104.90 K(-15.8%) |
Dec 2011 | - | $124.60 K(-16.1%) |
Sep 2011 | - | $148.50 K(-26.6%) |
Jun 2011 | $202.30 K(-116.0%) | $202.30 K(+41.7%) |
Mar 2011 | - | $142.80 K(-110.4%) |
Dec 2010 | - | -$1.38 M(+4.0%) |
Sep 2010 | - | -$1.32 M(+4.6%) |
Jun 2010 | -$1.26 M(+22.6%) | -$1.26 M(-13.2%) |
Mar 2010 | - | -$1.46 M(+9.5%) |
Dec 2009 | - | -$1.33 M(+9.1%) |
Sep 2009 | - | -$1.22 M(+18.3%) |
Jun 2009 | -$1.03 M(+13.7%) | -$1.03 M(-10.6%) |
Mar 2009 | - | -$1.15 M(+2.7%) |
Dec 2008 | - | -$1.12 M(+5.3%) |
Sep 2008 | - | -$1.07 M(+17.5%) |
Jun 2008 | -$907.80 K(-4.7%) | -$907.80 K(+5.1%) |
Mar 2008 | - | -$863.90 K(-11.3%) |
Dec 2007 | - | -$974.10 K(+23.0%) |
Sep 2007 | - | -$791.80 K(-16.8%) |
Jun 2007 | -$952.10 K(+48.8%) | -$952.10 K(+113.2%) |
Mar 2007 | - | -$446.60 K(-43.8%) |
Dec 2006 | - | -$795.30 K(+106.8%) |
Sep 2006 | - | -$384.50 K(-39.9%) |
Jun 2006 | -$639.90 K(-31.0%) | -$639.90 K(-15.8%) |
Mar 2006 | - | -$760.00 K(+12.4%) |
Dec 2005 | - | -$676.10 K(-39.3%) |
Sep 2005 | - | -$1.11 M(+20.0%) |
Jun 2005 | -$927.80 K(+84.1%) | -$927.80 K(+222.0%) |
Mar 2005 | - | -$288.10 K(-84.0%) |
Dec 2004 | - | -$1.80 M(+246.9%) |
Sep 2004 | - | -$519.90 K(+3.2%) |
Jul 2004 | -$503.90 K(+822.9%) | -$503.90 K(+83.2%) |
Apr 2004 | - | -$275.00 K(-44.0%) |
Jan 2004 | - | -$491.50 K(+112.7%) |
Oct 2003 | - | -$231.10 K(+323.3%) |
Jul 2003 | -$54.60 K(-105.8%) | -$54.60 K(-109.9%) |
Apr 2003 | - | $549.40 K(-16.9%) |
Jan 2003 | - | $660.90 K(-17.7%) |
Oct 2002 | - | $803.10 K(-15.0%) |
Jul 2002 | $944.80 K(-49.7%) | $944.80 K(-15.9%) |
Apr 2002 | - | $1.12 M(-14.7%) |
Jan 2002 | - | $1.32 M(-15.4%) |
Oct 2001 | - | $1.56 M |
Jul 2001 | $1.88 M | - |
FAQ
- What is InMed Pharmaceuticals annual working capital?
- What is the all time high annual working capital for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual working capital year-on-year change?
- What is InMed Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly working capital year-on-year change?
What is InMed Pharmaceuticals annual working capital?
The current annual working capital of INM is $6.72 M
What is the all time high annual working capital for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual working capital is $19.61 M
What is InMed Pharmaceuticals annual working capital year-on-year change?
Over the past year, INM annual working capital has changed by -$2.61 M (-28.01%)
What is InMed Pharmaceuticals quarterly working capital?
The current quarterly working capital of INM is $5.84 M
What is the all time high quarterly working capital for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly working capital is $19.61 M
What is InMed Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, INM quarterly working capital has changed by -$2.69 M (-31.53%)